Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements announced a shareholders' meeting on May 2, 2025, to approve the Scheme of Amalgamation with Adani Cementation, requiring 75% public shareholder approval and separate SEBI clearance. The meeting will be held via video conference with e-voting from April 28 to May 1, 2025, for shareholders registered by April 25, 2025. Supporting documents are available on the company's website.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 31 March 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 31 March 2025

TECHM Tech Mahindra Limited Financial Results JINDALSTEL JINDAL STEEL LIMITED Financial Results BAJAJFINSV Bajaj Finserv Limited Financial Results BAJFINANCE Bajaj Finance Limited Financial Results DIVISLAB Divi's Laboratories Limited Financial Results OBEROIRLTY Oberoi Realty Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.